메뉴 건너뛰기




Volumn 18, Issue 12, 2011, Pages 2038-2042

Maintenance of immune response throughout childhood following serogroup C meningococcal conjugate vaccination in early childhood

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE;

EID: 83455210496     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05354-11     Document Type: Article
Times cited : (21)

References (25)
  • 1
    • 0141675219 scopus 로고    scopus 로고
    • Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England
    • DOI 10.1128/CDLI.10.5.780-786.2003
    • Andrews, N., R. Borrow, and E. Miller. 2003. Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England. Clin. Diagn. Lab. Immunol. 10:780-786. (Pubitemid 37129487)
    • (2003) Clinical and Diagnostic Laboratory Immunology , vol.10 , Issue.5 , pp. 780-786
    • Andrews, N.1    Borrow, R.2    Miller, E.3
  • 2
    • 57549114614 scopus 로고    scopus 로고
    • Association of a bacteriophage with meningococcal disease in young adults
    • Bille, E., et al. 2008. Association of a bacteriophage with meningococcal disease in young adults. PLoS One 3:e3885.
    • (2008) PLoS One , vol.3
    • Bille, E.1
  • 3
    • 74549171099 scopus 로고    scopus 로고
    • Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine
    • Borrow, R., et al. 2010. Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine. Clin. Vaccine Immunol. 17:154-159.
    • (2010) Clin. Vaccine Immunol. , vol.17 , pp. 154-159
    • Borrow, R.1
  • 4
    • 14844282302 scopus 로고    scopus 로고
    • Meningococcal surrogates of protection - Serum bactericidal antibody activity
    • DOI 10.1016/j.vaccine.2005.01.051
    • Borrow, R., P. Balmer, and E. Miller. 2005. Meningococcal surrogates of protection - serum bactericidal antibody activity. Vaccine 23:2222-2227. (Pubitemid 40341456)
    • (2005) Vaccine , vol.23 , Issue.17-18 , pp. 2222-2227
    • Borrow, R.1    Balmer, P.2    Miller, E.3
  • 5
    • 0036716435 scopus 로고    scopus 로고
    • Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection
    • Burrage, M., et al. 2002. Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection. Infect. Immun. 70:4946-4954.
    • (2002) Infect. Immun. , vol.70 , pp. 4946-4954
    • Burrage, M.1
  • 6
    • 77952004260 scopus 로고    scopus 로고
    • Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: Effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity
    • Campbell, H., N. Andrews, R. Borrow, C. Trotter, and E. Miller. 2010. Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity. Clin. Vaccine Immunol. 17:840-847.
    • (2010) Clin. Vaccine Immunol. , vol.17 , pp. 840-847
    • Campbell, H.1    Andrews, N.2    Borrow, R.3    Trotter, C.4    Miller, E.5
  • 8
    • 33846042245 scopus 로고    scopus 로고
    • Lessons from meningococcal carriage studies
    • DOI 10.1111/j.1574-6976.2006.00052.x
    • Caugant, D. A., G. Tzanakaki, and P. Kriz. 2007. Lessons from meningococcal carriage studies. FEMS Microbiol. Rev. 31:52-63. (Pubitemid 46058820)
    • (2007) FEMS Microbiology Reviews , vol.31 , Issue.1 , pp. 52-63
    • Caugant, D.A.1    Tzanakaki, G.2    Kriz, P.3
  • 9
    • 79251607440 scopus 로고    scopus 로고
    • Updated recommendations for use of meningococcal conjugate vaccines. Advisory Committee on Immunization Practices (ACIP), 2010
    • CDC
    • CDC. 2011. Updated recommendations for use of meningococcal conjugate vaccines. Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb. Mortal. Wkly. Rep. 60:72-76.
    • (2011) MMWR Morb. Mortal. Wkly. Rep. , vol.60 , pp. 72-76
  • 10
    • 4944225305 scopus 로고    scopus 로고
    • Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children
    • DOI 10.1016/j.vaccine.2004.04.027, PII S0264410X0400372X
    • Collins, C. L., et al. 2004. Immunogenicity and safety of a low-dose diphtheria, tetanus and acellular pertussis combination vaccine with either inactivated or oral polio vaccine as a pre-school booster in UK children. Vaccine 22:4262-4269. (Pubitemid 39330349)
    • (2004) Vaccine , vol.22 , Issue.31-32 , pp. 4262-4269
    • Collins, C.L.1    Salt, P.2    McCarthy, N.3    Chantler, T.4    Lane, L.5    Hemme, F.6    Diggle, L.7    Buttery, J.8    Kitchin, N.R.E.9    Moxon, E.R.10    Pollard, A.J.11
  • 11
    • 0017344016 scopus 로고
    • Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92
    • Glode, M. P., et al. 1977. Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92. J. Infect. Dis. 135:94-104.
    • (1977) J. Infect. Dis. , vol.135 , pp. 94-104
    • Glode, M.P.1
  • 13
    • 79951681571 scopus 로고    scopus 로고
    • Persistence of immunity following a booster dose of Haemophilus influenzae type B-meningococcal serogroup C glycoconjugate vaccine: Follow-up of a randomized controlled trial
    • Khatami, A., et al. 2011. Persistence of immunity following a booster dose of Haemophilus influenzae type B-meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trial. Pediatr. Infect. Dis. J. 30:197-202.
    • (2011) Pediatr. Infect. Dis. J. , vol.30 , pp. 197-202
    • Khatami, A.1
  • 16
    • 65349110862 scopus 로고    scopus 로고
    • An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS)
    • National Advisory Committee on Immunization
    • National Advisory Committee on Immunization. 2009. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS). Can. Commun. Dis. Rep. 35:1-40.
    • (2009) Can. Commun. Dis. Rep. , vol.35 , pp. 1-40
  • 17
    • 77952993552 scopus 로고    scopus 로고
    • Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: A phase 4 clinical trial
    • Perrett, K. P., et al. 2010. Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial. Clin. Infect. Dis. 50:1601-1610.
    • (2010) Clin. Infect. Dis. , vol.50 , pp. 1601-1610
    • Perrett, K.P.1
  • 19
    • 67649491062 scopus 로고    scopus 로고
    • Investigation of serum bactericidal activity in childhood and adolescence 3-6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine
    • Sakou, I. I., et al. 2009. Investigation of serum bactericidal activity in childhood and adolescence 3-6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine. Vaccine 27:4408-4411.
    • (2009) Vaccine , vol.27 , pp. 4408-4411
    • Sakou, I.I.1
  • 20
    • 13844254496 scopus 로고    scopus 로고
    • Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine
    • DOI 10.1097/01.inf.0000151029.58752.27
    • Snape, M. D., et al. 2005. Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine. Pediatr. Infect. Dis. J. 24:128-131. (Pubitemid 40250770)
    • (2005) Pediatric Infectious Disease Journal , vol.24 , Issue.2 , pp. 128-131
    • Snape, M.D.1    Kelly, D.F.2    Green, B.3    Moxon, E.R.4    Borrow, R.5    Pollard, A.J.6
  • 22
    • 33751555760 scopus 로고    scopus 로고
    • Serogroup C meningococcal glycoconjugate vaccine in adolescents: Persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization
    • DOI 10.1086/508776
    • Snape, M. D., et al. 2006. Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization. Clin. Infect. Dis. 43:1387-1394. (Pubitemid 44845637)
    • (2006) Clinical Infectious Diseases , vol.43 , Issue.11 , pp. 1387-1394
    • Snape, M.D.1    Kelly, D.F.2    Salt, P.3    Green, S.4    Snowden, C.5    Diggle, L.6    Borkowski, A.7    Yu, L.-M.8    Moxon, E.R.9    Pollard, A.J.10
  • 23
    • 0037424112 scopus 로고    scopus 로고
    • Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era
    • DOI 10.1016/S0264-410X(02)00630-8, PII S0264410X02006308
    • Trotter, C., R. Borrow, N. Andrews, and E. Miller. 2003. Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era. Vaccine 21:1094-1098. (Pubitemid 36139939)
    • (2003) Vaccine , vol.21 , Issue.11-12 , pp. 1094-1098
    • Trotter, C.1    Borrow, R.2    Andrews, N.3    Miller, E.4
  • 24
    • 3242768475 scopus 로고    scopus 로고
    • Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
    • DOI 10.1016/S0140-6736(04)16725-1, PII S0140673604167251
    • Trotter, C. L., N. J. Andrews, E. B. Kaczmarski, E. Miller, and M. E. Ramsay. 2004. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 364:365-367. (Pubitemid 38970013)
    • (2004) Lancet , vol.364 , Issue.9431 , pp. 365-367
    • Trotter, C.L.1    Andrews, N.J.2    Kaczmarski, E.B.3    Miller, E.4    Ramsay, M.E.5
  • 25
    • 21244452423 scopus 로고    scopus 로고
    • Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination
    • DOI 10.1093/aje/kwi160
    • Trotter, C. L., N. J. Gay, and W. J. Edmunds. 2005. Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination. Am. J. Epidemiol. 162:89-100. (Pubitemid 40885005)
    • (2005) American Journal of Epidemiology , vol.162 , Issue.1 , pp. 89-100
    • Trotter, C.L.1    Gay, N.J.2    Edmunds, W.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.